Uveitis Treatment Market
According to Intent Market Research, the Uveitis Treatment Market is expected to grow from USD 0.6 billion in 2024-e at a CAGR of 8.3% to touch USD 1.1 billion by 2030. The Uveitis Treatment Market is dominated by key players such as Novartis International AG, Johnson & Johnson, Roche Holding AG, AbbVie Inc., Bayer AG, Regeneron Pharmaceuticals, Inc., Amgen Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb, Sanofi S.A., Eli Lilly and Co., Santen Pharmaceutical Co., Ltd., UCB Pharma, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International.